Blood clot prevention after hip or knee replacement: what patients should know

Hip and knee replacement temporarily create several conditions that favor clotting. Surgery activates the body's normal clotting response, the leg may move less for a period of time, and swelling can slow venous blood flow. A clot that forms in a deep vein is called a deep vein thrombosis, or DVT. If part of a clot travels to the lungs, it can cause a pulmonary embolism, or PE.

Modern joint-replacement pathways are designed around prevention from the beginning. Early walking, ankle movement, mechanical compression when appropriate, and medication are used together rather than relying on a single step. The American Academy of Orthopaedic Surgeons advises patients that blood-clot prevention is a routine part of recovery after joint replacement. AAOS patient guidance after joint replacement.

Getting out of bed and walking soon after surgery is not only about proving that the new joint works. Muscle contractions in the calf help push venous blood back toward the heart. Ankle pumps and short, frequent walks continue that job between therapy sessions.

That does not mean walking as far as possible on day one. The goal is safe, frequent movement that fits your pain control, balance, blood pressure, and anesthesia recovery. A patient who becomes lightheaded or unsafe when standing should be stabilized first rather than pushed through a mobility target.

Many joint-replacement programs use intermittent pneumatic compression devices around the lower legs during the early recovery period. These sleeves periodically squeeze the calf to improve venous blood flow while the patient is resting. Compression stockings may also be used in selected patients.

Mechanical measures are helpful, but they are not automatically a substitute for medication in patients who need pharmacologic prophylaxis. The full plan depends on clot risk, bleeding risk, the operation, and the patient's ability to mobilize.

There is no single medication that is best for every hip or knee replacement patient. The American Society of Hematology guideline allows either aspirin or an anticoagulant after total hip or knee replacement, while emphasizing that the certainty of some comparisons is limited. When an anticoagulant is chosen, the guideline discusses direct oral anticoagulants and low-molecular-weight heparin as options. ASH surgical VTE guideline.

A large randomized Australian trial, CRISTAL, added an important caution to the aspirin discussion. In patients undergoing primary hip or knee replacement for osteoarthritis, aspirin monotherapy produced more symptomatic venous thromboembolism than enoxaparin. That does not mean every patient should receive enoxaparin. It does mean that medication choice should be individualized rather than treated as a one-size-fits-all habit. CRISTAL randomized trial.

Do not start, stop, double, or substitute aspirin or another blood thinner on your own. Follow the written discharge instructions for your specific operation. The medication-after-surgery guide explains how clot prevention fits alongside pain medicines and other postoperative prescriptions.

Your surgeon considers both clot risk and bleeding risk. Factors that can raise concern include a personal history of DVT or PE, active cancer, major immobility, certain clotting disorders, obesity, advanced age, significant varicose veins, and some medical comorbidities. The importance of each factor varies, and no single checklist replaces clinical judgment.

Risk also changes over time. A patient who is walking normally before surgery but becomes unexpectedly immobile afterward may need the plan reassessed. Conversely, a stronger anticoagulant is not automatically safer if the patient's bleeding risk is high.

The duration depends on the joint replaced, the medication selected, and the patient's individual risk profile. Guidelines and clinical pathways use different durations. Some regimens are measured in a couple of weeks, while others continue for several weeks after surgery.

Your written plan should tell you exactly what to take, how much, how often, and when to stop. If those instructions are unclear, confirm them rather than guessing. This is especially important if another physician already prescribes anticoagulation for atrial fibrillation, a previous clot, a heart condition, or another reason.

Not every swollen leg after joint replacement has a blood clot. Swelling and bruising are common after surgery. The concern is a change that is new, one-sided, or out of proportion to the expected recovery pattern.

A clot that reaches the lungs can be life-threatening. Sudden shortness of breath, chest pain especially with breathing, coughing up blood, fainting, or severe unexplained rapid heart rate should not wait for a routine office message. Call 911 or seek emergency care immediately.

AAOS patient education specifically identifies shortness of breath and chest pain as warning signs that a clot may have traveled to the lungs. AAOS warning signs.

Clot-prevention medicines work by reducing the blood's tendency to clot, so bleeding is the other side of the decision. Call for medical guidance if you develop persistent wound bleeding, large unexplained bruising, blood in the urine or stool, repeated nosebleeds that do not stop, or another concerning change while taking an anticoagulant.

Severe bleeding, vomiting blood, black tarry stool with weakness, fainting, or symptoms of internal bleeding require urgent evaluation. Do not simply skip doses for several days without discussing the situation with the prescribing team unless emergency clinicians direct you otherwise.

Patients traveling between O‘ahu, Hilo, Kona, Maui, Kaua‘i, or farther away have an additional practical issue: sitting during travel. The safest approach is to coordinate the timing of the flight with the surgical team and follow the same prescribed clot-prevention plan during the travel window. Do not take extra aspirin or an extra anticoagulant dose just because you are flying.

For patients who will travel for surgery, the interisland travel guide explains how visits, imaging, surgery, early recovery, and the trip home can be coordinated in advance.

Most patients do not need to memorize every thrombosis guideline. They need a clear plan they can actually follow.

• American Academy of Orthopaedic Surgeons: After Your Joint Replacement Surgery
• American Society of Hematology guideline: prevention of VTE in surgical hospitalized patients
• International Consensus Meeting on VTE: Hip & Knee recommendations
• CRISTAL randomized trial: aspirin versus enoxaparin after hip or knee arthroplasty